DOTA-Bombesin (1-14) (TFA)

DOTA-Bombesin (1-14) TFA is composed of chelator DOTA and Bombesin. DOTA-Bombesin (1-14) TFA is used for research of cancer through combination with radioactive elements. DOTA-Bombesin (1-14) TFA can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).

C90H136N28O25S.xC2HF3O2

O=C(N[C@@H](C)C(N[C@@H](C(C)C)C(NCC(N[C@H](C(N[C@@H](CC(C)C)C(N[C@H](C(N)=O)CCSC)=O)=O)CC1=CN=CN1)=O)=O)=O)[C@@H](NC([C@H](CCC(N)=O)NC([C@H](CC(N)=O)NC(CNC([C@@H](NC([C@H](CCCNC(N)=N)NC([C@H](CCC(N)=O)NC([C@H](CCC2)N2C(CN(CCN(CC3)CC(O)=O)CCN(CCN3CC(O)=O)CC(O)=O)=O)=O)=O)=O)CC(C=C4)=CC=C4O)=O)=O)=O)=O)CC5=CNC6=CC=CC=C56.OC(C(F)(F)F)=O.[x]

Radionuclide-Drug Conjugates (RDCs)

RDC Bifunctional Chelator

98.1

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

Blue Ice